2/4
12:16 am
aytu
Aytu BioPharma Inc (AYTU) Q2 2026 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
Medium
Report
Aytu BioPharma Inc (AYTU) Q2 2026 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]
2/3
08:11 pm
aytu
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript [Seeking Alpha]
2/3
07:55 pm
aytu
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates [Yahoo! Finance]
Medium
Report
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates [Yahoo! Finance]
2/3
07:12 am
aytu
Aytu BioPharma (NASDAQ:AYTU) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
Aytu BioPharma (NASDAQ:AYTU) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
2/2
07:34 am
aytu
Earnings To Watch: Aytu BioPharma Inc (AYTU) Reports Q2 2026 Result [Yahoo! Finance]
Medium
Report
Earnings To Watch: Aytu BioPharma Inc (AYTU) Reports Q2 2026 Result [Yahoo! Finance]
1/27
07:06 pm
aytu
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026 [Yahoo! Finance]
Low
Report
Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026 [Yahoo! Finance]
1/20
08:07 pm
aytu
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript [Seeking Alpha]
12/10
08:08 am
aytu
Aytu BioPharma (NASDAQ:AYTU) had its price target raised by analysts at Ascendiant Capital Markets from $12.50 to $13.00. They now have a "buy" rating on the stock.
Low
Report
Aytu BioPharma (NASDAQ:AYTU) had its price target raised by analysts at Ascendiant Capital Markets from $12.50 to $13.00. They now have a "buy" rating on the stock.
11/26
06:43 am
aytu
Aytu BioPharma (NASDAQ:AYTU) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
High
Report
Aytu BioPharma (NASDAQ:AYTU) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/14
12:10 am
aytu
Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ... [Yahoo! Finance]
Medium
Report
Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Highlights: Strong ADHD Portfolio Performance ... [Yahoo! Finance]
11/13
09:27 pm
aytu
Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call Transcript [Seeking Alpha]